The magazine Focus reports on CRP apheresis in COVID-19
11.02.2022
Focus published an interview with an early COVID patient who was treated with CRP apheresis
The ÄrzteZeitung reports on successes with CRP apheresis in severe COVID-19 pneumonia
18.01.2022
The article states that selective CRP apheresis could be an effective therapy option for COVID-19 patients with respiratory failure and greatly increased CRP levels, and that initial data from the German registry CACOV are encouraging.
Rainer Mohr is the new CFO of Pentracor GmbH since the beginning of the year
Hennigsdorf, January 20, 2022 - The medical technology company Pentracor GmbH from Hennigsdorf (convertible bond ISIN: DE000A289XB9, WKN: A289XB) has employed Rainer Mohr as a new Chief Financial Officer (CFO) since January 1, 2022.
In this function, Rainer Mohr controls and implements the strategic development of the company in all commercial and financial areas in close coordination and cooperation with the management of Pentracor.
Pentracor CAMI-1 study praised as groundbreaking
11.01.2022
The authors of the review article “Immune Mechanisms of Plaque Instability” from the Charité Cardiology Department describe the Pentracor CAMI-1 study “CRP apheresis in Acute Myocardial Infarction” as groundbreaking.
American Journal of Case Reports: CRP apheresis in severe COVID-19
30.12.2021
"Most Viewed" article: A new case report from 7 patients suggests the effectiveness of CRP apheresis in severe COVID-19.
Ahmed Sheriff named one of the most important Brandenburgers in 2022
03.01.2022
The MOZ names our managing director the “most important Brandenburger”
Announcement: Web seminar with experience report on CRP apheresis against COVID-19
20.01.2022
We are represented with a lecture at the web seminar Biotech vs. SARS-CoV-2: A BioBilanz.
Business magazine Forum reports on Pentracor and "Zukunftspreis"
09.12.2021
Our two founders Ahmed Sheriff and Birgit Vogt are on the cover of the current issue of the business magazine of the IHK Potsdam and the figureheads for the title topic: Zukunftspreis Brandenburg 2021 .
Pentracor wins "Zukunftspreis Brandenburg" 2021
November 16, 2021
The medical technology company Pentracor GmbH from Hennigsdorf wins the Zukunftspreis Brandenburg 2021, the most important business award in the state of Brandenburg. From 82 applicants and 12 finalists, the jury selected six prize winners and one company as a special prize winner. The award ceremony took place on November 12 at the Airport Center Berlin Schönefeld. "We are very honored by this award," said Dr. Ahmed Sheriff, Managing Director of Pentracor GmbH.
Pentracor was awarded the "Zukunftspreis Brandenburg" 2021
12.11.2021
Pentracor was awarded the "Zukunftspreis Brandenburg" 2021!
A total of six companies and one special prize winner were awarded the state's most important business prize, the "Zukunftspreis Brandenburg" 2021. With their business ideas and developments, they convinced the top-class jury of 16 of their special achievements for the Brandenburg economy. Brandenburg's Minister President Dr. Dietmar Woidke congratulated the winners at the Holiday Inn Berlin Airport Conference Centre in Schönefeld and pointed out the importance of regional companies for the entire state of Brandenburg. In several rounds, they prevailed against a total of 82 applicants.
